Creo Medical Group (LON:CREO – Get Free Report) issued its earnings results on Monday. The company reported GBX (8) (($0.11)) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Creo Medical Group had a negative net margin of 73.93% and a negative return on equity of 41.79%.
Creo Medical Group Trading Up 0.4%
Shares of LON:CREO opened at GBX 10.04 ($0.13) on Monday. Creo Medical Group has a 12-month low of GBX 9.22 ($0.12) and a 12-month high of GBX 37.20 ($0.49). The stock has a market cap of £40.58 million, a PE ratio of -1.59 and a beta of 0.86. The business has a 50 day moving average of GBX 11.16 and a 200-day moving average of GBX 15.25. The company has a quick ratio of 2.19, a current ratio of 3.24 and a debt-to-equity ratio of 29.96.
About Creo Medical Group
The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.
Featured Stories
- Five stocks we like better than Creo Medical Group
- 3 Dividend Kings To Consider
- Deere Powers Ahead: Q2 Beat, Analyst Boosts, More Upside
- Using the MarketBeat Dividend Yield Calculator
- 3 Companies That Just Raised Dividends; 2 to Buy, 1 to Avoid
- Breakout Stocks: What They Are and How to Identify Them
- CAVA’s Explosive Growth Makes It a Must-Watch Stock
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
